File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Cleavage and Polyadenylation Specific Factor 1 Promotes Tumor Progression via Alternative Polyadenylation and Splicing in Hepatocellular Carcinoma

TitleCleavage and Polyadenylation Specific Factor 1 Promotes Tumor Progression via Alternative Polyadenylation and Splicing in Hepatocellular Carcinoma
Authors
Keywordshepatocellular carcinoma
alternative polyadenylation
cleavage and polyadenylation specific factor 1
cleavage and polyadenylation
alternative splicing
Issue Date2021
PublisherFrontiers Research Foundation. The Journal's web site is located at https://www.frontiersin.org/journals/cell-and-developmental-biology
Citation
Frontiers in Cell and Developmental Biology, 2021, v. 9, p. article no. 616835 How to Cite?
AbstractAlternative polyadenylation (APA) is an important post-transcriptional regulatory mechanism required for cleavage and polyadenylation (CPA) of the 3′ untranslated region (3′ UTR) of mRNAs. Several aberrant APA events have been reported in hepatocellular carcinoma (HCC). However, the regulatory mechanisms underlying APA remain unclear. In this study, we found that the expression of cleavage and polyadenylation specific factor 1 (CPSF1), a major component of the CPA complex, was significantly increased in HCC tissues and correlated with unfavorable survival outcomes. Knockdown of CPSF1 inhibited HCC cell proliferation and migration, whereas overexpression of CPSF1 caused the opposite effect. Based on integrative analysis of Iso-Seq and RNA-seq data from HepG2.2.15 cells, we identified a series of transcripts with differential 3′ UTR lengths following the knockdown of CPSF1. These transcripts were related to the biological functions of gene transcription, cytoskeleton maintenance, and endomembrane system transportation. Moreover, knockdown of CPSF1 induced an increase in alternative splicing (AS) events in addition to APA. Taken together, this study provides new insights into our understanding of the post-transcriptional regulatory mechanisms in HCC and implies that CPSF1 may be a potential prognostic biomarker and therapeutic target for HCC.
Persistent Identifierhttp://hdl.handle.net/10722/300923
ISSN
2021 Impact Factor: 6.081
2020 SCImago Journal Rankings: 2.452
PubMed Central ID
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorChen, SL-
dc.contributor.authorZhu, ZX-
dc.contributor.authorYang, X-
dc.contributor.authorLiu, L-
dc.contributor.authorHe, YF-
dc.contributor.authorYang, MM-
dc.contributor.authorGuan, X-
dc.contributor.authorWang, X-
dc.contributor.authorYun, JP-
dc.date.accessioned2021-07-06T03:12:06Z-
dc.date.available2021-07-06T03:12:06Z-
dc.date.issued2021-
dc.identifier.citationFrontiers in Cell and Developmental Biology, 2021, v. 9, p. article no. 616835-
dc.identifier.issn2296-634X-
dc.identifier.urihttp://hdl.handle.net/10722/300923-
dc.description.abstractAlternative polyadenylation (APA) is an important post-transcriptional regulatory mechanism required for cleavage and polyadenylation (CPA) of the 3′ untranslated region (3′ UTR) of mRNAs. Several aberrant APA events have been reported in hepatocellular carcinoma (HCC). However, the regulatory mechanisms underlying APA remain unclear. In this study, we found that the expression of cleavage and polyadenylation specific factor 1 (CPSF1), a major component of the CPA complex, was significantly increased in HCC tissues and correlated with unfavorable survival outcomes. Knockdown of CPSF1 inhibited HCC cell proliferation and migration, whereas overexpression of CPSF1 caused the opposite effect. Based on integrative analysis of Iso-Seq and RNA-seq data from HepG2.2.15 cells, we identified a series of transcripts with differential 3′ UTR lengths following the knockdown of CPSF1. These transcripts were related to the biological functions of gene transcription, cytoskeleton maintenance, and endomembrane system transportation. Moreover, knockdown of CPSF1 induced an increase in alternative splicing (AS) events in addition to APA. Taken together, this study provides new insights into our understanding of the post-transcriptional regulatory mechanisms in HCC and implies that CPSF1 may be a potential prognostic biomarker and therapeutic target for HCC.-
dc.languageeng-
dc.publisherFrontiers Research Foundation. The Journal's web site is located at https://www.frontiersin.org/journals/cell-and-developmental-biology-
dc.relation.ispartofFrontiers in Cell and Developmental Biology-
dc.rightsThis Document is Protected by copyright and was first published by Frontiers. All rights reserved. It is reproduced with permission.-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjecthepatocellular carcinoma-
dc.subjectalternative polyadenylation-
dc.subjectcleavage and polyadenylation specific factor 1-
dc.subjectcleavage and polyadenylation-
dc.subjectalternative splicing-
dc.titleCleavage and Polyadenylation Specific Factor 1 Promotes Tumor Progression via Alternative Polyadenylation and Splicing in Hepatocellular Carcinoma-
dc.typeArticle-
dc.identifier.emailGuan, X: xyguan@hku.hk-
dc.identifier.authorityGuan, X=rp00454-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.3389/fcell.2021.616835-
dc.identifier.pmid33748106-
dc.identifier.pmcidPMC7969726-
dc.identifier.scopuseid_2-s2.0-85102892405-
dc.identifier.hkuros323255-
dc.identifier.volume9-
dc.identifier.spagearticle no. 616835-
dc.identifier.epagearticle no. 616835-
dc.identifier.isiWOS:000630012500001-
dc.publisher.placeSwitzerland-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats